Tomorrow, Halia’s CEO David Bearss Ph.D., will take part in Scintillant Bioscience virtual panel to discuss: “Visualizing the Present and Future: Imaging 2D Cell Culture and 3D Organoids for Therapeutics Discovery.” He will be joined by Russ Teichert, MBA, PhD, Founder and CEO of Scintillant Bioscience, Beth Hoffman, Ph.D., CEO of Origami Therapeutics, and Andrea Mazzocchi, Ph.D., VP of Partnerships at Pathos. The event will be held at 4:00p.m. (EST) To register for the event, visit the LinkedIn event page: https://lnkd.in/ezAJdQDj Talking Therapeutics is a Scintillant Bioscience initiative that aims to bridge the gap between laboratory research and clinical outcomes. This virtual series assembles a panel of industry experts, researchers, and clinicians to discuss emerging trends, share insights, and tackle the most pressing challenges in therapeutics discovery and development today. #inflammasome #chronicinflammation #NLRP3 #therapeutics
This will be fantastic. Looking forward to it!
Founder and CEO, Scintillant Bioscience
11moThanks for posting this! One point of clarification: the event will be held tomorrow, November 8 at 4:00 pm Eastern Time (1:00 pm Pacific Time). Also, if you go to the event page by following the link in the post above, you will need to click on the event link to actually register and receive a Zoom link to join the meeting. Here is a short cut to the registration link: https://us02web.zoom.us/meeting/register/tZwvduiprDwrGNTM6zBedZvQwub1fhOBDcaV#/registration Please join us!